RVL Pharmaceuticals Revenue and Competitors

Bridgewater, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • RVL Pharmaceuticals's estimated annual revenue is currently $165.9M per year.(i)
  • RVL Pharmaceuticals's estimated revenue per employee is $11,850,000
  • RVL Pharmaceuticals's current valuation is $94.1M. (January 2022)

Employee Data

  • RVL Pharmaceuticals has 14 Employees.(i)
  • RVL Pharmaceuticals grew their employee count by -22% last year.

RVL Pharmaceuticals's People

NameTitleEmail/Phone
1
EVP & Chief Operating OfficerReveal Email/Phone
2
VP, Commercial Human Resources & Corporate CommunicationsReveal Email/Phone
3
EVP, COOReveal Email/Phone
4
VP, U.S. SalesReveal Email/Phone
5
VP, Regulatory Affairs & Quality AssuranceReveal Email/Phone
6
VP Supply Chain & ProcurementReveal Email/Phone
7
VP QualityReveal Email/Phone
8
VP, Information TechnologyReveal Email/Phone
9
VP Program Mgmt & Contracts OfficerReveal Email/Phone
10
SVP, Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is RVL Pharmaceuticals?

RVL Pharmaceuticals, Inc. is a new operating subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT), and was created for the purpose of bringing Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% to market. RVL Pharmaceuticals, Inc. is dedicated to developing unique partnerships with customers, as well as making Upneeq® available exclusively through our fully-owned and integrated pharmacy. Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.

keywords:N/A

N/A

Total Funding

14

Number of Employees

$165.9M

Revenue (est)

-22%

Employee Growth %

$94.1M

Valuation

N/A

Accelerator

RVL Pharmaceuticals News

2022-04-06 - RVL Pharmaceuticals plc Announces Preliminary First Quarter ...

RVL Pharmaceuticals plc Announces Preliminary First Quarter 2022 UPNEEQ® Net Product Sales Results. April 06, 2022 06:50 ET | Source: RVL Pharmaceuticals...

2022-03-30 - RVL Pharmaceuticals plc Reports Fourth Quarter and Full ...

RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Preliminary First Quarter 2022 UPNEEQ® Revenue...

2022-03-30 - RVL Pharmaceuticals: A Makeover For An Ugly Duckling

Hapless Osmotica renamed itself RVL Pharmaceuticals. · It has a novel business model which vastly simplifies its business. · Encouragingly, recent...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M148%N/A
#2
$165.9M14-22%N/A
#3
$1.3M1525%N/A
#4
$1.3M157%N/A
#5
$4.3M17-45%N/A